Even with those alarming numbers, the US FDA approvals of disease-modifying therapies (DMTs) such as Leqembi (lecanemab) and ...
This report by Towards Healthcare, a sister firm of Precedence Research, offers an in-depth analysis of the contamination ...
The global sales of microbial identification are estimated to be worth USD 4.69 billion in 2025 and anticipated to reach a ...
Sexual state-regulated insulin signaling and vulval epithelial cues engage distinct pathways to remodel the F-actin ...